Making Cardiomyocytes from Pluripotent Stem Cells
Peter Karagiannis1, Yoshinori Yoshida2
1Center for iPS Cell Research and Application, Kyoto University, Kyoto, Japan.
Methods in Molecular Biology (Clifton, N.J.)
|July 24, 2021
Summary
Pluripotent stem cell-derived cardiomyocytes (PSC-CMs) offer promise for heart disease research and therapies. However, challenges remain in optimizing their electromechanical properties, tissue integration, and genetic manipulation for studying heart disorders.
Area of Science:
- Cardiovascular Research
- Stem Cell Biology
- Regenerative Medicine
Background:
- Pluripotent stem cells can differentiate into cardiomyocyte lineages (PSC-CMs).
- PSC-CMs are valuable for heart disease modeling, drug discovery, and cell therapies.
- Current differentiation protocols require further advancement to realize the full potential of PSC-CMs.
Purpose of the Study:
- To address the challenges in deriving and utilizing pluripotent stem cell-derived cardiomyocytes (PSC-CMs).
- To outline current methodologies for overcoming obstacles in PSC-CM research and application.
- To discuss the potential of PSC-CMs in understanding and treating cardiac disorders.
Main Methods:
- Consideration of challenges in PSC-CM differentiation and application.
- Review of current methodologies offering partial solutions.
- Discussion of strategies for improving electromechanical properties and tissue integration.
Main Results:
- Identification of key obstacles in PSC-CM development, including achieving proper electromechanical function and tissue formation.
- Exploration of methods for genetic manipulation of PSC-CMs to study disease mechanisms.
- Partial solutions and current approaches are presented to address these challenges.
Conclusions:
- Further advances in differentiation protocols are crucial for harnessing the therapeutic potential of PSC-CMs.
- Overcoming challenges in PSC-CM development will enhance their utility in disease modeling and regenerative medicine.
- Continued research is needed to fully integrate PSC-CMs into clinical applications for heart conditions.


